1529-0131/asset/cover.gif?v=1&s=104d5c2bb8ef72deba26790b855af7ab80697a0e "Arthritis & Rheumatism")
Drs. Hoffman and Merkel have also been investigators of studies evaluating anti–tumor necrosis factor (anti-TNF) therapies in Wegener's granulomatosis and giant cell arteritis, which were partially funded by Centocor, Immunex, and Amgen. Dr. Brasington has also been an investigator of a study evaluating the role of anti-TNF therapy in rheumatoid arthritis, which was funded by Amgen, and has received speaker's fees from Immunex, Amgen, and Centocor.
1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
Research Article
You have full text access to this OnlineOpen article
Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis
Article first published online: 6 JUL 2004
DOI: 10.1002/art.20300
Copyright © 2004 by the American College of Rheumatology
Additional Information
How to Cite
Hoffman, G. S., Merkel, P. A., Brasington, R. D., Lenschow, D. J. and Liang, P. (2004), Anti–tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis & Rheumatism, 50: 2296–2304. doi: 10.1002/art.20300
Publication History
- Issue published online: 6 JUL 2004
- Article first published online: 6 JUL 2004
- Manuscript Accepted: 1 MAR 2004
- Manuscript Received: 13 NOV 2003
Funded by
- National Institute of Arthritis and Musculoskeletal and Skin Diseases. Grant Number: K24 AR-2224-01A1
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , Efficacy of combination therapy of anti-TNF-α antibody infliximab and methotrexate in refractory entero-Behçet’s disease, Modern Rheumatology, 2010,
- 2, European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis, Current Opinion in Rheumatology, 2010, 22, 1, 49
- 3, , , , , , , Takayasu arteritis in children and adolescents, Rheumatology, 2010, 49, 10, 1806
- 4
- 5, Takayasu arteritis—advances in diagnosis and management, Nature Reviews Rheumatology, 2010, 6, 7, 406
- 6, , , , , Takayasu arteritis: assessment of response to medical therapy based on clinical activity criteria and imaging techniques, Rheumatology International, 2010,
- 7, , , , , , , Takayasu's Arteritis in a Patient with Crohn's Disease: An Unexpected Association during Infliximab Therapy, Internal Medicine, 2010, 49, 2, 179
- 8, Takayasu's arteritis with associated aortic insufficiency and coronary ostial obliteration, Journal of the American Academy of Nurse Practitioners, 2010, 22, 6Direct Link:
- 9, , , TNF- antagonists beyond approved indications: stories of success and prospects for the future, QJM, 2010, 103, 12, 917
- 10
- 11, , Advances in the use of biologic agents for the treatment of systemic vasculitis, Current Opinion in Rheumatology, 2009, 21, 1, 3
- 12, , , , , , , Infliximab therapy in pediatric Takayasu’s arteritis: report of two cases, Rheumatology International, 2009, 31, 1, 93
- 13
- 14, , , Refractory Takayasu arteritis in a 65-year-old Caucasian woman, Journal of the European Academy of Dermatology and Venereology, 2009, 23, 2Direct Link:
- 15, , , , , , , Takayasu Arteritis and Pregnancy, Obstetrical & Gynecological Survey, 2009, 64, 4, 258
- 16, , , , Takayasu disease on the centenary of its discovery, Japanese Journal of Ophthalmology, 2009, 53, 2, 81
- 17, Drug Insight: anti-tumor necrosis factor therapies for the vasculitic diseases, Nature Clinical Practice Rheumatology, 2008,
- 18, , , , , , , , Efficacy of tumor necrosis factor α blockade in primary central nervous system vasculitis resistant to immunosuppressive treatment, Arthritis Care & Research, 2008, 59, 2Direct Link:
- 19, , , Empfehlungen der European League Against Rheumatism (EULAR) zur Behandlung von „Großgefäßvaskulitiden“, Zeitschrift für Rheumatologie, 2008, 68, 3, 260
- 20, , , Lewis–Sumner syndrome associated with infliximab therapy in rheumatoid arthritis, Muscle & Nerve, 2008, 38, 4Direct Link:
- 21, , , , Successful treatment of a patient with takayasu arteritis using a humanized anti–interleukin-6 receptor antibody, Arthritis & Rheumatism, 2008, 58, 4Direct Link:
- 22, , , , Takayasu's arteritis as a cause of diagnostic difficulties in a 16-year-old girl, Annales UMCS, Medicina, 2008, 63, 1, 38
- 23, , Takayasu’s arteritis, Current Treatment Options in Cardiovascular Medicine, 2008, 10, 2, 164
- 24
- 25, , , A Patient with Takayasu's Arteritis and Rheumatoid Arthritis Who Responded to Tacrolimus Hydrate, Internal Medicine, 2007, 46, 22, 1873
- 26
- 27, , , Limitations of therapy and a guarded prognosis in an american cohort of takayasu arteritis patients, Arthritis & Rheumatism, 2007, 56, 3Direct Link:
- 28, , , , , Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritis, Clinical Rheumatology, 2007, 26, 11, 1871
- 29, , , Update on the use of biologics in primary systemic vasculitides, Expert Review of Clinical Immunology, 2007, 3, 6, 901
- You have free access to this content30, , Extended indications for anti-tumor necrosis factor-α therapy, APLAR Journal of Rheumatology, 2006, 9, 2Direct Link:
- 31, , , , Infliximab in Takayasu arteritis: a safe alternative?, Clinical Rheumatology, 2006, 26, 6, 984
- 32, , , , , , , , , , , , , Infliximab is Effective for Takayasu Arteritis Refractory to Glucocorticoid and Methotrexate, Internal Medicine, 2006, 45, 5, 313
- 33, , Rare association of antiphospholipid syndrome and Takayasu arteritis, Clinical Rheumatology, 2006, 26, 5, 821
- 34, , , , , Takayasu's arteritis: a review of the literature, Internal and Emergency Medicine, 2006, 1, 2, 105
- 35, , , , , , , , Takayasu’s arteritis with skin manifestations in a patient with inflammatory bowel disease: coincidence or concurrence?, Clinical Rheumatology, 2006, 26, 6, 996
- 36, Vasculitis treatment – new therapeutic approaches, European Journal of Pediatrics, 2006, 165, 6, 351
- 37, , Advances in the medical and surgical treatment of Takayasu arteritis, Current Opinion in Rheumatology, 2005, 17, 1, 16
- 38
- 39, , Infections Associated with Tumor Necrosis Factor-α Antagonists, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2005, 25, 9Direct Link:
- 40, , Infliximab-Responsive Uveitis and Vasculitis in a Patient With Takayasu Arteritis, JCR: Journal of Clinical Rheumatology, 2005, 11, 4, 213
- 41, , Successful Treatment of Childhood Onset Refractory Polyarteritis Nodosa With Tumor Necrosis Factor Alpha Blockade, JCR: Journal of Clinical Rheumatology, 2005, 11, 4, 219
- 42